Resumen

AZNAR, E. et al. Hipercalcemia de origen tumoral: estudio de 133 casos. Rev Diagn Biol [online]. 2001, vol.50, n.1, pp.28-32. ISSN 0034-7973.

Background and objective: To analyze the hypercalcemia of a tumoral origin detected in an Oncologic Hospital of 130 beds. The following variables have been considered: Topographic tumoral localization, biochemistry profile and overall survival.  Patients and methods: We have recorded the values of corrected calcium in 10.283 patients with the diagnosis of cancer. Serical calcium values equal or higher than 11 mg/dl (2.75 mmol/l) were considered hypercalcemia.  Results: We have found a total incidence of 1,3%, the highest rates were detected in breast cancer and hematologics tumors. The overall survival was of 312 days.  Conclusions: Despite the reported frequent of the complication, our study has not been found a high incidence (1,3%). This finding suggests a worse prognosis feature in most of the studied cancers. Youngest patients showed the highest rates of hypercalcemia and the highest levels of the alkaline phosphatase and lactate dehydrogenase.

Palabras clave : Hypercalcemia; cancer incidence; overall survival; side.